Melanoma Clinical Trial

Investigating Participation Patterns Among Stage IV Melanoma Patients

Summary

Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Aged ≥ 18 years old
Diagnosis of stage IV melanoma
Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion Criteria:

Female patients who are currently pregnant or nursing
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Inability to perform regular electronic reporting

Study is for people with:

Melanoma

Estimated Enrollment:

500

Study ID:

NCT06093594

Recruitment Status:

Not yet recruiting

Sponsor:

Power Life Sciences Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Power Life Sciences
San Francisco California, 94107, United States More Info

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

500

Study ID:

NCT06093594

Recruitment Status:

Not yet recruiting

Sponsor:


Power Life Sciences Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.